Trastuzumab Cardiac Side Effects: Only Time Will Tell Journal Articles

authors

• Levine, Mark Norman

status

• published 

publication date

• November 1, 2005

has subject area

• 1103 Clinical Sciences (FoR)
• 1112 Oncology and Carcinogenesis (FoR)
• Antibodies, Monoclonal (MeSH)
• Antibodies, Monoclonal, Humanized (MeSH)
• Antineoplastic Agents (MeSH)
• Breast Neoplasms (MeSH)
• Female (MeSH)
• Heart (MeSH)
• Heart Failure (MeSH)
• Humans (MeSH)
• Neoadjuvant Therapy (MeSH)
• Oncology & Carcinogenesis (Science Metrix)
• Receptor, ErbB-2 (MeSH)
• Time Factors (MeSH)
• Trastuzumab (MeSH)
• Ventricular Dysfunction, Left (MeSH)

published in

• Journal of Clinical Oncology  Journal

keywords

• Antibodies, Monoclonal
• Antibodies, Monoclonal, Humanized
• Antineoplastic Agents
• Breast Neoplasms
• Female
• Heart
• Heart Failure
• Humans
• Neoadjuvant Therapy
• Receptor, ErbB-2
• Time Factors
• Trastuzumab
• Ventricular Dysfunction, Left

Digital Object Identifier (DOI)

• 10.1200/jco.2005.04.1558

PubMed ID

• 16258081

start page

• 7775

end page

• 7776

volume

• 23

issue

• 31